Quality of Life and a Surveillant Endocannabinoid System

被引:27
作者
de Melo Reis, Ricardo Augusto [1 ]
Isaac, Alinny Rosendo [1 ]
Freitas, Hercules Rezende [2 ]
de Almeida, Mariana Macedo [3 ]
Schuck, Patricia Fernanda [2 ]
Ferreira, Gustavo Costa [2 ]
Andrade-da-Costa, Belmira Lara da Silveira [4 ]
Trevenzoli, Isis Hara [3 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Neurochem, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Lab Neuroenerget & Inborn Errors Metab, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Mol Endocrinol Lab, Rio De Janeiro, Brazil
[4] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Ctr Biosci, Recife, PE, Brazil
关键词
THC; tetrahydrocannabinol; cannabidiol; diet; exercise; meditation; anandamide; BDNF; metabolic programming; ACID AMIDE HYDROLASE; HIGH-FAT DIET; TYPE-1 CANNABINOID RECEPTOR; SUBCUTANEOUS ADIPOSE-TISSUE; TRANSGENIC MOUSE MODEL; CB2; RECEPTOR; BETA-CARYOPHYLLENE; IN-VIVO; MEDITERRANEAN DIET; PARKINSONS-DISEASE;
D O I
10.3389/fnins.2021.747229
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The endocannabinoid system (ECS) is an important brain modulatory network. ECS regulates brain homeostasis throughout development, from progenitor fate decision to neuro- and gliogenesis, synaptogenesis, brain plasticity and circuit repair, up to learning, memory, fear, protection, and death. It is a major player in the hypothalamic-peripheral system-adipose tissue in the regulation of food intake, energy storage, nutritional status, and adipose tissue mass, consequently affecting obesity. Loss of ECS control might affect mood disorders (anxiety, hyperactivity, psychosis, and depression), lead to drug abuse, and impact neurodegenerative (Alzheimer's, Parkinson, Huntington, Multiple, and Amyotrophic Lateral Sclerosis) and neurodevelopmental (autism spectrum) disorders. Practice of regular physical and/or mind-body mindfulness and meditative activities have been shown to modulate endocannabinoid (eCB) levels, in addition to other players as brain-derived neurotrophic factor (BDNF). ECS is involved in pain, inflammation, metabolic and cardiovascular dysfunctions, general immune responses (asthma, allergy, and arthritis) and tumor expansion, both/either in the brain and/or in the periphery. The reason for such a vast impact is the fact that arachidonic acid, a precursor of eCBs, is present in every membrane cell of the body and on demand eCBs synthesis is regulated by electrical activity and calcium shifts. Novel lipid (lipoxins and resolvins) or peptide (hemopressin) players of the ECS also operate as regulators of physiological allostasis. Indeed, the presence of cannabinoid receptors in intracellular organelles as mitochondria or lysosomes, or in nuclear targets as PPAR gamma might impact energy consumption, metabolism and cell death. To live a better life implies in a vigilant ECS, through healthy diet selection (based on a balanced omega-3 and -6 polyunsaturated fatty acids), weekly exercises and meditation therapy, all of which regulating eCBs levels, surrounded by a constructive social network. Cannabidiol, a diet supplement has been a major player with anti-inflammatory, anxiolytic, antidepressant, and antioxidant activities. Cognitive challenges and emotional intelligence might strengthen the ECS, which is built on a variety of synapses that modify human behavior. As therapeutically concerned, the ECS is essential for maintaining homeostasis and cannabinoids are promising tools to control innumerous targets.</p>
引用
收藏
页数:28
相关论文
共 379 条
  • [51] Cannabidiol, neuroprotection and neuropsychiatric disorders
    Campos, Alline C.
    Fogaca, Manoela V.
    Sonego, Andreza B.
    Guimaraes, Francisco S.
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 112 : 119 - 127
  • [52] Differential genome-wide DNA methylation patterns in childhood obesity
    Cao-Lei, Lei
    Elgbeili, Guillaume
    Szyf, Moshe
    Laplante, David P.
    King, Suzanne
    [J]. BMC RESEARCH NOTES, 2019, 12 (1)
  • [53] Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing to Drug Addiction: Effect of Ovarian Hormones
    Castelli, Maria Paola
    Fadda, Paola
    Casu, Angelo
    Spano, Maria Sabrina
    Casti, Alberto
    Fratta, Walter
    Fattore, Liana
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (13) : 2100 - 2113
  • [54] Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease
    Celorrio, Marta
    Fernandez-Suarez, Diana
    Rojo-Bustamante, Estefania
    Echeverry-Alzate, Victor
    Ramirez, Maria J.
    Hillard, Cecilia J.
    Lopez-Moreno, Jose A.
    Maldonad, Rafael
    Oyarzabal, Julen
    Franco, Rafael
    Aymerich, Maria S.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2016, 57 : 94 - 105
  • [55] Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
    Chagas, Marcos Hortes N.
    Zuardi, Antonio W.
    Tumas, Vitor
    Pena-Pereira, Marcio Alexandre
    Sobreira, Emmanuelle T.
    Bergamaschi, Mateus M.
    dos Santos, Antonio Carlos
    Teixeira, Antonio Lucio
    Hallak, Jaime E. C.
    Crippa, Jose Alexandre S.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (11) : 1088 - 1092
  • [56] Carnitine palmitoyltransferase 1C reverses cellular senescence of MRC-5 fibroblasts via regulating lipid accumulation and mitochondrial function
    Chen, Panpan
    Zhang, Qianbin
    Zhang, Huizhen
    Gao, Yue
    Zhou, Yanying
    Chen, Yixin
    Guan, Lihuan
    Jiao, Tingying
    Zhao, Yingyuan
    Huang, Min
    Bi, Huichang
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (02) : 958 - 970
  • [57] Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
    Cheng, David
    Spiro, Adena S.
    Jenner, Andrew M.
    Garner, Brett
    Karl, Tim
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (04) : 1383 - 1396
  • [58] β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway
    Cheng, Yujie
    Dong, Zhi
    Liu, Sha
    [J]. PHARMACOLOGY, 2014, 94 (1-2) : 1 - 12
  • [59] Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor
    Chiurchiu, Valerio
    Lanuti, Mirko
    Catanzaro, Giuseppina
    Fezza, Filomena
    Rapino, Cinzia
    Maccarrone, Mauro
    [J]. ATHEROSCLEROSIS, 2014, 233 (01) : 55 - 63
  • [60] Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
    Choi, In-Young
    Ju, Chung
    Jalin, Angela M. A. Anthony
    Lee, Da In
    Prather, Paul L.
    Kim, Won-Ki
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (03) : 928 - 939